Nutrient quality
Freeze-dried ginkgo and gotu kola form a coherent botanical pairing. Modest doses and absent active-marker standardization limit likely potency.
.| $ 23.24 | ||
| $ 23.24 |
The serving contains 175 mg of freeze-dried ginkgo leaf and 100 mg of gotu kola. Their shared traditional use in circulation and cognition gives the formula a clear theme without unrelated fillers.
Freeze-dried whole leaf is not equivalent to a standardized ginkgo extract, and no flavonglycoside, terpene-lactone, or ginkgolic-acid specification is supplied. Gotu kola also lacks an extract ratio or active-marker standardization.
The product may suit adults who prefer whole-herb preparations and accept a gentler, less predictable approach. It is not the strongest choice for dependable focus, broad vision nutrition, or comparison with clinically characterized ginkgo extracts.
Freeze-dried ginkgo and gotu kola form a coherent botanical pairing. Modest doses and absent active-marker standardization limit likely potency.
.All listed active amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and important extract details are not supplied.
.The supplied average rating is strong and comes from a substantial rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.
.The focused formula provides fair value at a moderate serving cost. Modest doses and absent standardization weaken competitiveness.
.Ginkgo and gotu kola are relevant to circulation and traditional cognitive support. The freeze-dried whole-herb format lacks the standardized markers used in stronger ginkgo evidence.
Both herb amounts are disclosed, but flavone glycosides, terpene lactones, and ginkgolic acid limits are absent. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.
Ginkgo and gotu kola offer plausible support for mental clarity and circulation. The ginkgo is freeze-dried whole herb rather than the standardized extract used in stronger clinical evidence.
Amounts are transparent, but active-marker and purity specifications are missing. The formula is simple yet likely underpowered for a dependable productivity effect.
Ginkgo and gotu kola target cerebral circulation and traditional memory support. Evidence is limited by whole freeze-dried ginkgo leaf and unstandardized gotu kola rather than clinically characterized extracts.
The whole-leaf ginkgo and modest gotu-kola amounts do not establish a clinically effective active dose. Amounts and plant identities are clear, but active markers, extract ratios, and ginkgolic-acid controls are absent. Ginkgo may increase bleeding risk when used with anticoagulant or antiplatelet medicines.
Ginkgo and gotu kola have traditional cognitive relevance, but the formula uses whole-herb material rather than a verified clinical extract. Direct focus effects are therefore uncertain.
Amounts are stated clearly, yet no active-marker or ginkgolic-acid specification is provided. The two-botanical formula is focused but lacks reliable dose depth and broader alertness support.
| Ingredient | Amount per serving |
|---|---|
Ginkgo biloba, Freeze-Dried | 175 mg |
Gotu Kola | 100 mg |
Freeze-dried ginkgo leaf provides whole-herb material rather than a standardized extract. The amount is clearly disclosed, but active-marker and ginkgolic acid specifications are absent. The modest serving cost does not compensate for the lack of a verified clinical extract.
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.